Literature DB >> 9371553

Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse.

A Bukreyev1, S S Whitehead, B R Murphy, P L Collins.   

Abstract

The small hydrophobic protein SH of human respiratory syncytial virus (RSV) is a short transmembrane surface protein of unknown function. A full-length cDNA of RSV strain A2 (subgroup A) antigenomic RNA was modified such that the entire SH gene, including the transcription signals and the complete mRNA-encoding sequence, was deleted and replaced by a synthetic intergenic region. This reduced the length of the antigenome by 398 nucleotides and ablated expression of 1 of the 10 RSV mRNAs. Recombinant virus containing this engineered deletion was recovered, and the absence of the SH gene was confirmed by reverse transcription in conjunction with PCR. Northern blot analysis of intracellular RNAs and gel electrophoresis of labeled intracellular proteins confirmed the lack of expression of the SH mRNA and protein. The absence of the SH gene did not noticeably affect RNA replication, but two effects on transcription were noted. First, synthesis of the G, F, and M2 mRNAs was increased, presumably due to their being one position closer to the promoter in the gene order. Second, transcription of genes downstream of the engineered site exhibited a steeper gradient of polarity. On monolayers of HEp-2 cells, the SH-minus virus produced syncytia which were at least equivalent in size to those of the wild type and produced plaques which were 70% larger. Furthermore, the SH-minus virus grew somewhat better (up to 12.6-fold) than wild-type recombinant RSV in certain cell lines. While the function of the SH protein remains to be determined, it seems to be completely dispensable for growth in tissue culture and fusion function. When inoculated intranasally into mice, the SH-minus virus resembled the wild-type recombinant virus in its efficiency of replication in the lungs, whereas it replicated 10-fold less efficiently in the upper respiratory tract. In mice, the SH-minus and wild-type recombinant viruses were similarly immunogenic and effective in inducing resistance to virus challenge.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371553      PMCID: PMC230197     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

Review 1.  Do Vpu and Vpr of human immunodeficiency virus type 1 and NB of influenza B virus have ion channel activities in the viral life cycles?

Authors:  R A Lamb; L H Pinto
Journal:  Virology       Date:  1997-03-03       Impact factor: 3.616

2.  Fusion glycoprotein of human parainfluenza virus type 3: nucleotide sequence of the gene, direct identification of the cleavage-activation site, and comparison with other paramyxoviruses.

Authors:  M K Spriggs; R A Olmsted; S Venkatesan; J E Coligan; P L Collins
Journal:  Virology       Date:  1986-07-15       Impact factor: 3.616

3.  mRNA sequence and deduced amino acid sequence of the mumps virus small hydrophobic protein gene.

Authors:  N Elango; J Kövamees; T M Varsanyi; E Norrby
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

4.  The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.

Authors:  P R Johnson; M K Spriggs; R A Olmsted; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  The A and B subgroups of human respiratory syncytial virus: comparison of intergenic and gene-overlap sequences.

Authors:  P R Johnson; P L Collins
Journal:  J Gen Virol       Date:  1988-11       Impact factor: 3.891

6.  Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus.

Authors:  S Levine; R Klaiber-Franco; P R Paradiso
Journal:  J Gen Virol       Date:  1987-09       Impact factor: 3.891

7.  cDNA cloning and transcriptional mapping of nine polyadenylylated RNAs encoded by the genome of human respiratory syncytial virus.

Authors:  P L Collins; G W Wertz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein.

Authors:  E E Walsh; J Hruska
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

9.  Identification and predicted sequence of a previously unrecognized small hydrophobic protein, SH, of the paramyxovirus simian virus 5.

Authors:  S W Hiebert; R G Paterson; R A Lamb
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

10.  The 1A protein of respiratory syncytial virus is an integral membrane protein present as multiple, structurally distinct species.

Authors:  R A Olmsted; P L Collins
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

View more
  105 in total

1.  The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription.

Authors:  A Bermingham; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil.

Authors:  J M Matthews; T F Young; S P Tucker; J P Mackay
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  The major attenuating mutations of the respiratory syncytial virus vaccine candidate cpts530/1009 specify temperature-sensitive defects in transcription and replication and a non-temperature-sensitive alteration in mRNA termination.

Authors:  K Juhasz; B R Murphy; P L Collins
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  The central conserved cystine noose of the attachment G protein of human respiratory syncytial virus is not required for efficient viral infection in vitro or in vivo.

Authors:  Michael N Teng; Peter L Collins
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Cleavage at the furin consensus sequence RAR/KR(109) and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture.

Authors:  Gert Zimmer; Karl-Klaus Conzelmann; Georg Herrler
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

6.  Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand.

Authors:  Alexander Kotelkin; Elena A Prikhod'ko; Jeffrey I Cohen; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

7.  The human respiratory syncytial virus matrix protein is required for maturation of viral filaments.

Authors:  Ruchira Mitra; Pradyumna Baviskar; Rebecca R Duncan-Decocq; Darshna Patel; Antonius G P Oomens
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

8.  The small hydrophobic protein of the human respiratory syncytial virus forms pentameric ion channels.

Authors:  Siok-Wan Gan; Edward Tan; Xin Lin; Dejie Yu; Juejin Wang; Gregory Ming-Yeong Tan; Ardcharaporn Vararattanavech; Chiew Ying Yeo; Cin Huang Soon; Tuck Wah Soong; Konstantin Pervushin; Jaume Torres
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

9.  Complete sequence of the RNA genome of pneumonia virus of mice (PVM).

Authors:  Christine D Krempl; Elaine W Lamirande; Peter L Collins
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

10.  Genetic recombination during coinfection of two mutants of human respiratory syncytial virus.

Authors:  Kirsten M Spann; Peter L Collins; Michael N Teng
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.